Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
Ploumen EH, Buiten RA, Zocca P, Doggen CJM, Jessurun GAJ, Schotborgh CE, Roguin A, Danse PW, Benit E, Aminian A, Anthonio RL, Somi S, Linssen GCM, Hartmann M, Kok MM, von Birgelen C. Ploumen EH, et al. Catheter Cardiovasc Interv. 2021 Aug 1;98(2):E188-E196. doi: 10.1002/ccd.29594. Epub 2021 Mar 10. Catheter Cardiovasc Interv. 2021. PMID: 33694294 Free PMC article.
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.
Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van der Heijden LC, Kok MM, Danse PW, Schotborgh CE, Scholte M, de Man FHAF, Linssen GCM, von Birgelen C. Buiten RA, et al. Among authors: ploumen eh. JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776. JAMA Cardiol. 2019. PMID: 31111862 Free PMC article. Clinical Trial.
Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
Buiten RA, Ploumen EH, Zocca P, Doggen CJM, Danse PW, Schotborgh CE, Scholte M, van Houwelingen KG, Stoel MG, Hartmann M, Tjon Joe Gin RM, Somi S, Linssen GCM, Kok MM, von Birgelen C. Buiten RA, et al. Among authors: ploumen eh. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1650-1660. doi: 10.1016/j.jcin.2019.04.054. Epub 2019 Aug 14. JACC Cardiovasc Interv. 2019. PMID: 31422087 Free article. Clinical Trial.
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
Ploumen EH, Buiten RA, Kok MM, Doggen CJM, van Houwelingen KG, Stoel MG, de Man FHAF, Hartmann M, Zocca P, Linssen GCM, Doelman C, Kant GD, von Birgelen C. Ploumen EH, et al. Catheter Cardiovasc Interv. 2020 Aug;96(2):E110-E118. doi: 10.1002/ccd.28536. Epub 2019 Oct 17. Catheter Cardiovasc Interv. 2020. PMID: 31625262 Free PMC article. Clinical Trial.
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.
Buiten RA, Ploumen EH, Zocca P, Doggen CJM, van Houwelingen KG, Danse PW, Schotborgh CE, Stoel MG, Scholte M, Linssen GCM, de Man FHAF, von Birgelen C. Buiten RA, et al. Among authors: ploumen eh. Catheter Cardiovasc Interv. 2020 Nov;96(5):E508-E515. doi: 10.1002/ccd.28886. Epub 2020 Apr 1. Catheter Cardiovasc Interv. 2020. PMID: 32237060 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 32332217
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years.
Buiten RA, Ploumen EH, Zocca P, Doggen CJM, Jessurun GAJ, Schotborgh CE, Roguin A, Danse PW, Benit E, Aminian A, van Houwelingen KG, Schramm AR, Stoel MG, Somi S, Hartmann M, Linssen GCM, von Birgelen C. Buiten RA, et al. Among authors: ploumen eh. JACC Cardiovasc Interv. 2020 May 11;13(9):1100-1109. doi: 10.1016/j.jcin.2020.01.230. JACC Cardiovasc Interv. 2020. PMID: 32381186 Free article. Clinical Trial.
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trials.
Ploumen EH, Buiten RA, Doggen CJM, Stoel MG, van Houwelingen KG, Schotborgh CE, Jessurun GAJ, Roguin A, Danse PW, Benit E, Aminian A, Linssen GCM, de Man FHAF, Hartmann M, Buiten DG, Kok MM, Zocca P, von Birgelen C; TWENTE I-IV trial investigators. Ploumen EH, et al. Am Heart J. 2020 Oct;228:109-115. doi: 10.1016/j.ahj.2020.07.003. Epub 2020 Jul 12. Am Heart J. 2020. PMID: 32882569 Free article. Clinical Trial.
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS.
Hommels TM, Hermanides RS, Berta B, Fabris E, De Luca G, Ploumen EH, von Birgelen C, Kedhi E. Hommels TM, et al. Among authors: ploumen eh. Cardiovasc Diabetol. 2020 Oct 2;19(1):165. doi: 10.1186/s12933-020-01116-2. Cardiovasc Diabetol. 2020. PMID: 33008407 Free PMC article.
37 results